Dexcom vs Stryker: revenue, profit, margins and growth compared
Dexcom brought in $4.7B of revenue in fiscal 2025, Stryker $25.1B in fiscal 2025. Revenue changed by +15.6% at Dexcom and +11.2% at Stryker on the year before, so Dexcom grew faster. Dexcom kept 17.9% of its revenue as net profit, Stryker 12.9%. Free cash flow was $1.1B at Dexcom and $4.3B at Stryker.
Fiscal years as each company reports them; the two may end in different months.
Questions about Dexcom and Stryker
Which is bigger by revenue, Dexcom or Stryker?
Stryker is bigger by revenue: $25.1B in fiscal 2025, against $4.7B for Dexcom in fiscal 2025.
Which keeps more of its revenue as profit, Dexcom or Stryker?
Dexcom had a net margin of 17.9% in fiscal 2025; Stryker had 12.9% in fiscal 2025.
Which grew revenue faster, Dexcom or Stryker?
In their latest fiscal years revenue changed by +15.6% at Dexcom and +11.2% at Stryker.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.